Age Related Macular Degeneration (ARMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)
Conditions
Keywords
Treatment burden, ARMD, RVO, DME, anti-VEGF
Brief summary
The study compares the perceived treatment burden in patients undergoing intravitreal anti-VEGF treatment for either wet age related macular degeneration, macular edema after retinal vein occlusions or diabetic macular edema. This study is the first to the investigator's knowledge to compare treatment burden between all three patient groups, which also differ in age and socioeconomic circumstances. The results are of interest to all ophthalmologists who prescribe anti-VEGF treatments, as they show factors which can influence patient adherence und thus the efficacy of said therapies.
Interventions
None listed
Sponsors
Hospital Hietzing
Scientific fund of the City of Vienna
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* undergone a minimum of 5 IVT's and had visited the retina clinic for at least 6 months
Exclusion criteria
* eye surgery in the preceding six months * notable cognitive impairment, such as dementia * age \<18 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Severitiy of subjective treatment burden due to intravitreal anti-VEGF therapy assessed by questionnaire | From May 2023 to April 2024 | The questionnaire was designed on the basis of the Longitudinal assessment of Adherence Factors to Intravitreal (anti-VEGF) Therapy (LAF-IVT) questionnaire. Patients were interviewed about their perceived treatment burden, their socioeconomic status, and demographic details. Different aspects of treatment burden were graden by the patients as "no", "little", "moderate", "great" or "extreme buden". |
Countries
Austria
Outcome results
None listed